Stock listing

Telo Genomics Corp.

Selected listing: A2PV0Q · LS · EUR · DE

Telo Genomics Corp. (Lang & Schwarz: A2PV0Q), Health Services. Latest release Sep 29, 2026: Telo Genomics Reports Additional Clinical Research Results…

A2PV0Q:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: A2PV0Q
Asset type: Stock
Sector: Health Services
Industry: Medical/Nursing Services
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Telo Genomics Corp.

Telo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing

September 29, 2026

Telo Genomics Announces Clinical Research Results Evidencing Utility of Its Telomere Analysis Platform in Predicting Multiple Myeloma Relapse

September 15, 2026

Telo Genomics Grants Stock Options

August 4, 2026

Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment

July 16, 2026

Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma

July 9, 2026

All Telo Genomics Corp. news →

Research Telo Genomics Corp.

Telo Genomics Corp. company profile

View the public company page for Telo Genomics Corp. on 6ix.

Telo Genomics Corp. news

Read company news and market updates connected to Telo Genomics Corp..

Telo Genomics Corp. investor events

Find investor webinars, events, and replay context for Telo Genomics Corp..